Ionis Pharma (IONS) Tops Q4 EPS by 33c

Ionis Pharma (NASDAQ: IONS) reported Q4 EPS of $0.21, $0.33 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $160.3 million versus the consensus estimate of $97.47 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance